Expertise
Advancing Personalized Medicine Through Integrative Research and Clinical Excellence
Translational research in personalized medicine: genomics, biomarkers, liquid biopsies & clinical validation.
- Receiver institution with a need to adopt a PM approach
- Clinical decision support systems for personalised medicine
- Theranostics (combined diagnostic + therapeutic approaches)
- Diagnostic tools (biomarkers, genetic tests, companion diagnostics)
- Personalised treatment pathways (tailored therapies, precision dosing)
- Patient management systems (decision-support tools, clinical workflows)
- Partial adoption of a PM solution (testing selected modules/components)
- Tools for secure data sharing & secondary use (pseudonymisation, FAIR data)
- Screening & early detection programs (risk stratification, predictive tools)
- Recovery & follow-up support systems (digital monitoring, apps, telemedicine)
- Cultural/organisational change approaches (staff training, workflow redesign)
- Data integration & interoperability solutions (EHRs, registries, data platforms)
- Standardisation & evaluation methodologies (protocols, metrics, QA/QC processes)
- Adaptation of care pathways for PM (embedding new tests/therapies into routine care)
- Patient engagement & empowerment strategies (self-management tools, shared decision-making)
- Adaptation of an existing PM solution to local context (language, IT environment, regulations)
- Initiating implementation of a PM solution (pilot site setup, proof-of-concept in clinical practice)